AbbVie and Tizona Therapeutics announce strategic collaboration

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, strategic collaboration to develop and commercialize CD39-targeted the...Read more

Bristol-Myers Squibb’s Sprycel® tablets now approved for pediatric patients

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ®(dasatinib) tablets to include the treatment of...Read more

AstraZeneca announces phase III trials for roxadustat

Drug Discovery |  News | 0 Comment | 03 Jan, 2019

AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy endpoints for the treatment of patients with anaemia in chronic kidney...Read more

Lupin gets FDA approval for Clobazam oral suspension

Drug Discovery |  News | 0 Comment | 01 Jan, 2019

Pharma major Lupin announced that it has received approval for its Clobazam Oral Suspension, 2.5 mg/mL from the United States Food and Drug Administration (FDA) to market a generic version ...Read more

Teva brings Generic Elidel Cream, 1% in US market

Drug Discovery |  News | 0 Comment | 01 Jan, 2019

Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Elidel®1 (pimecrolimus) Cream, 1% in the U.S. Pimecrolimus Cream, 1% is a topical prescript...Read more

BeiGene initiates clinical trial of Tislelizumab with cancer patients

Drug Discovery |  News | 0 Comment | 31 Dec, 2018

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, ...Read more

Chugai obtains approval for Genomic Mutation Analysis Program

Drug Discovery |  News | 0 Comment | 27 Dec, 2018

Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for “FoundationOne® CDx Cancer Genomic Profi...Read more

Cannabics files patent for personalized cannabimetic compositions modeling, production

Drug Discovery |  News | 0 Comment | 27 Dec, 2018

Cannabics Pharmaceuticals Inc., a world leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has filed a provisional patent applicatio...Read more

I-Mab gets UDFDA IND nod for exclusive monoclonal antibody TJM2

Drug Discovery |  Company results | 0 Comment | 24 Dec, 2018

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune disease...Read more

Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership

Drug Discovery |  News | 0 Comment | 20 Dec, 2018

Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) to facilitate the out-licensing of investigational med...Read more

Lexicon Pharma announces positive topline clinical data for LX9211

Drug Discovery |  News | 0 Comment | 19 Dec, 2018

Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211, a potent oral small molecule inhibitor of adaptor associated kinase...Read more

Bridge Bio signs $40M license agreement with Daewoong Pharma

Drug Discovery |  News | 0 Comment | 19 Dec, 2018

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a license agreement with Daewoong Pharmaceutical Co., Ltd. for development o...Read more

FibroGen's roxadustat OK'd in China

Drug Discovery |  News | 0 Comment | 18 Dec, 2018

Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-inducible prolyl hydroxylase inhibitor, for the treatment of anemia in...Read more

Avacta, LG Chem Life Sciences to develop novel drugs for cancer, inflammation

Drug Discovery |  News | 0 Comment | 13 Dec, 2018

UK-based Avacta Group plc , the developer of Affimer biotherapeutics and reagents and Korea's LG Chem Life Sciences, the life sciences division of the South Korean LG Group, recently ...Read more

Innovent declares positive result of IBI305, biosimilar to Avastin

Drug Discovery |  News | 0 Comment | 13 Dec, 2018

Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, announced that IBI305, a recombinant human...Read more

APLIDIN gets world-first approval for Multiple Myeloma

Drug Discovery |  News | 0 Comment | 11 Dec, 2018

Multiple myeloma patients from Australia will have world-first access to a new first-in-class drug developed to treat the disease, following approval by Australian regulatory authorities. ...Read more

TauRx's LMTXs gets FDA Orphan-drug Designation

Drug Discovery |  News | 0 Comment | 10 Dec, 2018

TauRx, a leader in neurodegenerative disease research, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to LMTX® for the "treatmen...Read more

Diamyd Medical raises SEK 58.4 million through redemption of warrants

Drug Discovery |  News | 0 Comment | 06 Dec, 2018

Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cell and medical technology. D...Read more